120 related articles for article (PubMed ID: 21498534)
41. Prognostic factors in patients with well-differentiated thyroid cancer presenting with pulmonary metastasis.
Showalter TN; Siegel BA; Moley JF; Baranski TJ; Grigsby PW
Cancer Biother Radiopharm; 2008 Oct; 23(5):655-9. PubMed ID: 18976119
[TBL] [Abstract][Full Text] [Related]
42. The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis.
Lin JD; Kuo SF; Huang BY; Lin SF; Chen ST
Nucl Med Commun; 2018 Dec; 39(12):1091-1096. PubMed ID: 30180044
[TBL] [Abstract][Full Text] [Related]
43. Defective efficacy of retinoic acid treatment in patients with metastatic thyroid carcinoma.
Courbon F; Zerdoud S; Bastie D; Archambaud F; Hoff M; Eche N; Berry I; Caron P
Thyroid; 2006 Oct; 16(10):1025-31. PubMed ID: 17042689
[TBL] [Abstract][Full Text] [Related]
44. Radioactive iodine refractoriness in Middle Eastern differentiated thyroid cancer: clinical outcome and risk factor analysis.
Parvathareddy SK; Siraj AK; Siraj N; Ahmed SO; Al-Rasheed M; Qadri Z; Siddiqui K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2024; 15():1326976. PubMed ID: 38812819
[TBL] [Abstract][Full Text] [Related]
45. Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome.
Dettmer M; Schmitt A; Steinert H; Moch H; Komminoth P; Perren A
Histopathology; 2012 Jun; 60(7):1045-51. PubMed ID: 22348590
[TBL] [Abstract][Full Text] [Related]
46. Differentiated thyroid cancer patients more than 60 years old paradoxically show an increased life expectancy.
Maier TM; Schober O; Gerß J; Görlich D; Wenning C; Schaefers M; Riemann B; Vrachimis A
J Nucl Med; 2015 Feb; 56(2):190-5. PubMed ID: 25613533
[TBL] [Abstract][Full Text] [Related]
47. Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients.
Pittas AG; Adler M; Fazzari M; Tickoo S; Rosai J; Larson SM; Robbins RJ
Thyroid; 2000 Mar; 10(3):261-8. PubMed ID: 10779141
[TBL] [Abstract][Full Text] [Related]
48. [Radiotherapy for Thyroid Cancer].
Jingu K; Maruoka S; Umezawa R; Takahashi N
Gan To Kagaku Ryoho; 2015 Jun; 42(6):666-9. PubMed ID: 26199238
[TBL] [Abstract][Full Text] [Related]
49. Radioactive iodine (131I) therapy for differentiated thyroid cancer in Japan: current issues with historical review and future perspective.
Higashi T; Kudo T; Kinuya S
Ann Nucl Med; 2012 Feb; 26(2):99-112. PubMed ID: 22081274
[TBL] [Abstract][Full Text] [Related]
50. To the editor: Long-term follow-up of patients with metastatic differentiated thyroid carcinoma.
Bertagna F; Giubbini R
World J Surg; 2010 Aug; 34(8):1988-9; author reply 1990. PubMed ID: 20151122
[No Abstract] [Full Text] [Related]
51. Multistage high-dose I-131 treatment for a nonthyroidectomized patient with metastatic differentiated thyroid cancer.
Ahn BC; Lee SW; Lee J
Clin Nucl Med; 2011 Dec; 36(12):e224-7. PubMed ID: 22064117
[No Abstract] [Full Text] [Related]
52. [Metastasis of differentiated cancers of the thyroid].
Baudin E; Schlumberger M
Ann Endocrinol (Paris); 1997; 58(4):326-9. PubMed ID: 9436482
[No Abstract] [Full Text] [Related]
53. Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update.
Ciarallo A; Rivera J
AJR Am J Roentgenol; 2020 Aug; 215(2):285-291. PubMed ID: 32551904
[No Abstract] [Full Text] [Related]
54. Iodine-131 whole-body scan for post-surgical follow-up of differentiated thyroid carcinoma.
Degrossi OJ; García del Río H; Degrossi EB
J Nucl Med; 1991 Sep; 32(9):1826. PubMed ID: 1880588
[No Abstract] [Full Text] [Related]
55. "Historical Vignettes".
DeNardo GL; Oldham RK
Cancer Biother Radiopharm; 1999 Apr; 14(2):65-6. PubMed ID: 10917743
[No Abstract] [Full Text] [Related]
56. Daily urine iodine excretion while consuming a low-iodine diet in preparation for radioactive iodine therapy in a high iodine intake area.
Kim HK; Lee SY; Lee JI; Jang HW; Kim SK; Chung HS; Tan AH; Hur KY; Kim JH; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2011 Dec; 75(6):851-6. PubMed ID: 21707689
[TBL] [Abstract][Full Text] [Related]
57. [Proceedings: Effect of radioactive iodine therapy on pulmonary metastasis of thyroid cancer].
Noguchi A; Murakami N; Ito J; Murao H
Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):403. PubMed ID: 4476482
[No Abstract] [Full Text] [Related]
58. [Postoperative treatment of differentiated thyroid carcinoma with intermediate recurrence risk].
Yang X; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):378-81. PubMed ID: 23987482
[TBL] [Abstract][Full Text] [Related]
59. Thyroxine dosing after I131Radioiodine ablation for differentiated thyroid cancer.
Clarke K; Gill V; Gerrard G
Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):559-60. PubMed ID: 21530195
[No Abstract] [Full Text] [Related]
60. Impact of age on survival in radioiodine refractory differentiated thyroid cancer patients.
Saïe C; Wassermann J; Mathy E; Chereau N; Leenhardt L; Tezenas du Montcel S; Buffet C
Eur J Endocrinol; 2021 May; 184(5):667-676. PubMed ID: 33667193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
